68Ga-NYM096(68Ga-NYM096) - _专利_临床

概要

基本信息

药物类型

诊断用放射药物

别名-

靶点-

作用方式-

作用机制-

治疗领域

肿瘤泌尿生殖系统疾病

在研适应症-

非在研适应症

转移性透明细胞性肾细胞癌

原研机构

北京协和医院

在研机构-

非在研机构

北京协和医院

权益机构-

最高研发阶段暂停临床1期

首次获批日期-

最高研发阶段(中国)暂停

特殊审评-

登录后查看时间轴

关联

2

项与 68Ga-NYM096 相关的临床试验

NCT07144748

/ RecruitingN/AIIT

68Ga-NYM096 PET/CT: Tracer Uptake in Various Kinds of Cancer

This is a prospective, single-center study aimed at evaluating the uptake characteristics of 68Ga-NYM096 PET/CT in various kinds of tumors including primary and metastatic lesions. Based on image analysis, this study will assess the uptake of various kinds of tumors using 68Ga-NYM096 PET/CT. The findings will provide critical insights into the tumor uptake on 68Ga-NYM096 PET/CT to identify the most promising indications for future application.

开始日期2025-08-01

申办/合作机构

北京协和医院

NCT06649682

/ Suspended临床1期IIT

Safety, Tolerability, Imaging Characteristics, and Efficacy of 68Ga-NYM096/177Lu-NYM096 in the Treatment of Patients With Metastatic Clear Cell Renal Cell Carcinoma

This is a single-center, phase I study. Patients with metastatic clear cell renal cell carcinoma will be recruited in this study to (Phase A) evaluate using 68Ga-NYM096 PET/CT and to (Phase B) treat with 177Lu-NYM096.
The study will be conducted in two phases. The purpose is Phase A: to evaluate the safety, tolerability, and imaging characteristics of 68Ga-NYM096 Phase B: to evaluate the safety, tolerability, and recommended phase 2 dose of 177Lu-NYM096

开始日期2024-11-21

申办/合作机构

北京协和医院

100 项与 68Ga-NYM096 相关的临床结果

登录后查看更多信息

100 项与 68Ga-NYM096 相关的转化医学

登录后查看更多信息

100 项与 68Ga-NYM096 相关的专利（医药）

登录后查看更多信息

100 项与 68Ga-NYM096 相关的药物交易

登录后查看更多信息